DE60325725D1 - Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs - Google Patents
Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebsInfo
- Publication number
- DE60325725D1 DE60325725D1 DE60325725T DE60325725T DE60325725D1 DE 60325725 D1 DE60325725 D1 DE 60325725D1 DE 60325725 T DE60325725 T DE 60325725T DE 60325725 T DE60325725 T DE 60325725T DE 60325725 D1 DE60325725 D1 DE 60325725D1
- Authority
- DE
- Germany
- Prior art keywords
- mab
- monoclonal antibody
- diagnosis
- optionally
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0207212A FR2840905B1 (fr) | 2002-06-12 | 2002-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
| PCT/FR2003/001772 WO2003106500A1 (fr) | 2002-06-12 | 2003-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60325725D1 true DE60325725D1 (de) | 2009-02-26 |
Family
ID=29595167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60325725T Expired - Lifetime DE60325725D1 (de) | 2002-06-12 | 2003-06-12 | Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7514231B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1511771B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4555681B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE420115T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003255671A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2489214C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60325725D1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2840905B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003106500A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7572914B2 (en) | 2003-12-19 | 2009-08-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| WO2006023931A2 (en) | 2004-08-18 | 2006-03-02 | Takeda San Diego, Inc. | Kinase inhibitors |
| EP1812439B2 (en) | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| JP2010505962A (ja) | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3944241B2 (ja) * | 1995-12-18 | 2007-07-11 | スージェン・インコーポレーテッド | Aur―1および/またはaur―2関連疾患の診断および処置 |
-
2002
- 2002-06-12 FR FR0207212A patent/FR2840905B1/fr not_active Expired - Lifetime
-
2003
- 2003-06-12 US US10/517,645 patent/US7514231B2/en not_active Expired - Lifetime
- 2003-06-12 EP EP03760023A patent/EP1511771B1/fr not_active Expired - Lifetime
- 2003-06-12 AU AU2003255671A patent/AU2003255671A1/en not_active Abandoned
- 2003-06-12 AT AT03760023T patent/ATE420115T1/de not_active IP Right Cessation
- 2003-06-12 JP JP2004513330A patent/JP4555681B2/ja not_active Expired - Lifetime
- 2003-06-12 DE DE60325725T patent/DE60325725D1/de not_active Expired - Lifetime
- 2003-06-12 WO PCT/FR2003/001772 patent/WO2003106500A1/fr not_active Ceased
- 2003-06-12 CA CA2489214A patent/CA2489214C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003255671A8 (en) | 2003-12-31 |
| JP2006513135A (ja) | 2006-04-20 |
| AU2003255671A1 (en) | 2003-12-31 |
| US20070117163A1 (en) | 2007-05-24 |
| CA2489214A1 (fr) | 2003-12-24 |
| ATE420115T1 (de) | 2009-01-15 |
| FR2840905A1 (fr) | 2003-12-19 |
| FR2840905B1 (fr) | 2006-07-07 |
| CA2489214C (fr) | 2013-08-06 |
| EP1511771B1 (fr) | 2009-01-07 |
| WO2003106500A1 (fr) | 2003-12-24 |
| EP1511771A1 (fr) | 2005-03-09 |
| JP4555681B2 (ja) | 2010-10-06 |
| US7514231B2 (en) | 2009-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE538809T1 (de) | Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff | |
| BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
| UA90082C2 (ru) | Выделенное моноклональное антитело человека, которое специфически связывается с cd25 человека и ингибирует связывание il-2 с cd25 | |
| ATE419516T1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
| JP2009525478A5 (cg-RX-API-DMAC7.html) | ||
| WO2005084109A3 (en) | Cancer specific gene mh15 | |
| DE60239059D1 (de) | Verfahren und zusammensetzungen zur hemmung, prävention oder verringerung des tumorzellwachstums beingen einer antiöstrogen-therapie resistent sind | |
| DE69717664D1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
| Ratkaj et al. | Microarray analysis of Dupuytren’s disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway | |
| Mak et al. | Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells | |
| ATE447715T1 (de) | Automatische glykofingerabdruck-strategie | |
| RU2013113314A (ru) | Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками | |
| WO2016203053A3 (en) | Methods of characterising cancer | |
| TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
| DE602005019694D1 (de) | Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose | |
| ATE420115T1 (de) | Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs | |
| RU2007141930A (ru) | Способ in vitro идентификации соединений для лечения рака | |
| IL190401A0 (en) | Antibodies against april as biomarkers for early prognosis of lymphoma patients | |
| FR2919061B1 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal. | |
| WO2004040312A3 (fr) | Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie | |
| WO2003068268A3 (en) | Treatment, diagnosis and imaging of disease | |
| DE60221115D1 (de) | Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose | |
| DE50313393D1 (de) | Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1 | |
| EA200802356A1 (ru) | Способ выявления и диагностики злокачественного новообразования, включающий праймеры и зонды для специфичного выявления маркера mage-a3 | |
| EA200600012A1 (ru) | Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |